Blog
RSS FeedPosted by Michael Wonder on 27 Jan 2022
The price of cystic fibrosis drugs is still too high
27 January 2022 - The Swedish Dental and Pharmaceutical Benefits Agency, TLV, has decided that Kaftrio and Kalydeco for cystic fibrosis ...
Posted by Michael Wonder on 27 Jan 2022
Do federal price transparency regulations neglect oncology patients?
24 January 2022 - The National Cancer Institute has identified measuring, understanding, and addressing cancer-related patient financial hardship as a top ...
Posted by Michael Wonder on 27 Jan 2022
2022 April price disclosure cycle – indicative prices
27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 08 Jan 2022
CMS takes action to lower out of pocket Medicare Part D prescription drug costs
6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to ...
Posted by Michael Wonder on 04 Jan 2022
Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices?
3 January 2022 - Astellas Pharma, a drug company headquartered in Japan, is charging U.S. patients $156,000 a year for ...
Posted by Michael Wonder on 20 Dec 2021
Biogen cuts price for Alzheimer’s drug Aduhelm by half
20 December 2021 - The drug has sold poorly since its approval in June due to concerns about its safety, effectiveness ...
Posted by Michael Wonder on 16 Dec 2021
Why the big questions about drug prices are rarely asked: it’s hard to do
16 December 2021 - Public debate over legislation to allow Medicare to negotiate the price of drugs has been dominated ...
Posted by Michael Wonder on 14 Dec 2021
FTC takes 'Pharma Bro' Martin Shkreli to trial over drug price hike
14 December 2021 - Shkreli is accused of masterminding an illegal scheme to jack up prices of the lifesaving drug Daraprim ...
Posted by Michael Wonder on 11 Dec 2021
‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit
10 December 2021 - It was the day before Christmas in 2015 and a senior director of national accounts at ...
Posted by Michael Wonder on 10 Dec 2021
Price disclosure 2022 April cycle outcomes summary
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...
Posted by Michael Wonder on 08 Dec 2021
Don’t destroy future drug development
8 December 2021 - With support faltering for the massive big-government blowout Congress is trying to jam through by Christmas, ...
Posted by Michael Wonder on 08 Dec 2021
PhRMA statement on White House drug pricing event
6 December 2021 - Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl released the following statement ...
Posted by Michael Wonder on 08 Dec 2021
$56K Alzheimer’s drug avoiding Biden’s cost curbs, for now
8 December 2021 - A new $56,000 a year Alzheimer’s medication that’s leading to one of the biggest increases ever in ...
Posted by Michael Wonder on 07 Dec 2021
Remarks by President Biden on prescription drug costs
6 December 2021 - Today, I’d like to talk about how we’re going to help millions of Americans protect and ...
Posted by Michael Wonder on 04 Dec 2021
Drug makers cut prices by 62% on average to get China state insurance listing
4 December 2021 - Pharmaceutical firms have agreed to cut prices by 61.7% on average for 67 medicines to be ...